Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial.

J Hematol · 2021 · PMC8734489 · PMID 35059087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Hepcidin, EPO and α-Klotho levels during the evaluation period Hepcidin decreased significantly in the CERA group, the median EPO increased in both groups but did not reach statistical significance; however, the levels in the CERA were higher (about double) than those observed in the EB group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.